Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy
Immune-related adverse events (irAEs) impact outcomes, with most research focusing on early prediction (baseline data), rather than near-term prediction (one cycle before the occurrence of irAEs and the current cycle). We aimed to explore the near-term predictive value of neutrophil/lymphocyte ratio...
Saved in:
Main Authors: | Yunyi Du (Author), Ying Zhang (Author), Wenqi Zhao (Author), Yuexiang Zhang (Author), Fei Su (Author), Xiaoling Zhang (Author), Weiling Li (Author), Wenqing Hu (Author), Yongai Li (Author), Jun Zhao (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers and risk factors for the early prediction of immune-related adverse events: a review
by: Ying Zhang, et al.
Published: (2022) -
PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report
by: YunYi Du, et al.
Published: (2022) -
Management and prediction of immune-related adverse events for PD1/PDL-1 immunotherapy in colorectal cancer
by: Liting Sun, et al.
Published: (2023) -
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
by: Weiling Li, et al.
Published: (2022) -
Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis
by: Peng-Fei Wang, et al.
Published: (2017)